NTBL(Delisted)
Notable Labs·NASDAQ
--
--(--)
NTBL Profile
Notable Labs, Ltd.
A clinical-stage treatment platform company developing predictive precision medicines for cancer patients
320 Hatch Drive, Foster City, California, 94404
--
Notable Labs, Ltd., was established in Israel on January 27, 2000. The company is a clinical-stage platform therapy company that develops predictive precision drugs for cancer patients. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable Bio-simulates a cancer treatment designed to predict whether a patient is likely to respond to this particular treatment. Notable's PPMP is designed to identify and select clinically responsive patients before they receive treatment, thereby accelerating the clinical development of this patient population. By continuously advancing and expanding PPMP's coverage in a variety of diseases and expected medical outcomes, Notable aims to become a leader in precision medicine and revolutionize the way patients seek and receive the treatment that best suits them — patient by patient and cancer by cancer. Notable believes that it creates a targeted, risk-reducing licensing strategy that delivers the medical effects and commercial value of a product in a faster, higher, and more likely way than traditional drug development. By changing the standard of historical care, Notable aims to create a huge positive impact for patients and the healthcare community.
